Navigation Links
ACT Obtains Exclusive License for Hemangioblast Technology in North America
Date:7/21/2011

unity-award/index.asp">won a National Institutes of Health (NIH) Director's Opportunity Award for research in "Translating Basic Science Discoveries into New and Better Treatments" under the American Recovery & Reinvestment Act of 2009. The NIH Award provides McLean Hospital and SCRMI with $1.9 million to explore the potential of protein-induced pluripotent stem (iPS) cells as a source of universal red blood cells and platelets for transfusion.  Drs. Lanza and Kim will continue to serve as principle investigators on this grant.

"We are very excited about this next step in our joint venture," said Hyung-Min Chung, Ph.D., chief technology officer of CHA Biotech and chief executive officer of SCRMI. "While still permitting us to leverage the combined expertise of our two companies, this new licensing and development arrangement should help to accelerate the development of clinical programs, and open the door to further government-sponsored research than had been available to SCRMI.  Fundamentally, we believe that the hemangioblast program has great potential to address many unmet medical needs through the use of stem cell technology, and feel that this realignment in licensing and research efforts is an important step towards CHA Biotech and ACT realizing those goals."

"Given the progress that has been made by our teams in the development of hemangioblast-derived products, coupled with bringing the scientists from the joint venture into ACT and Dr. Lanza's devotion to these programs, this new exclusive license affords ACT a unique new pipeline of therapeutic products, some of which are not that far from the clinic," added Gary Rabin, interim chairman and chief executive officer of ACT. "The market opportunities around diabetes-related diseases alone are vast.  Diabetes is the leading cause of blindness, non-traumatic limb amputations, and cardiovascular morbidity and mortality, each of which may be treatable using hemangioblast-deri
'/>"/>

SOURCE Advanced Cell Technology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
2. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
3. Occlutech Obtains Favourable Court Ruling in Patent Litigation in The Hague Against AGA Medical
4. China Sky One Medical, Inc. Obtains Production Rights for Nine New Drugs
5. NeoStem Obtains Exclusive Worldwide License to Innovative Stem Cell Technology and Applications for Anti-Aging Skin Rejuvenation Therapies
6. Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss
7. Sinovac Biotech Co. Ltd., Sinovacs Beijing Subsidiary, Obtains High-Tech Enterprise Status
8. Occlutech Obtains Favourable Ruling in Proceedings Initiated by AGA Medical
9. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
10. China Sky One Medical, Inc. Obtains SFDA Approvals for Geranium Ointment and Musk Liniment for Pain Relief
11. SemBioSys Genetics Inc. obtains up to $1.5 million in funding from AVAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... USA (PRWEB) May 17, 2013 •    First ... Globes Certified for sustainability ,     New facility will ... , Syngenta unveiled its new ... at the company’s RTP Innovation Center. The first of ... researchers to simulate any agricultural climate and precisely measure ...
(Date:5/17/2013)... May 17, 2013  Insero Health, Inc., a company ... epilepsy and related neurological disorders, is today reporting top-line ... compound INS001 in patients with drug-resistant epilepsy.  The data ... Trials (AED) Xll meeting by Dr. Steven ... of Insero,s Scientific Advisory Board.  In this study, INS001 ...
(Date:5/17/2013)... Brea, CA (PRWEB) May 17, 2013 IAC ... DisperSol Technologies, a start up laboratory needing to set up ... be moving to a larger facility within a year’s time. ... the knowledge that the laboratory is temporary? What is efficient ... 4 Series modular workstations from IAC Industries. The planners at ...
(Date:5/16/2013)... (PRWEB) May 16, 2013 In late 2012, ... to speak to doctors in China about Appearance Medicine ... NZ, this was her first trip to lecture in China, ... visited Guangzhou and Fuzhou, home to 12 and 7 million ... is very high at this point in time. As Dr. ...
Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy 2New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2
... NEEDHAM, Mass., Feb. 24 Environment of Care ... tips to better achieve and maintain their organization,s ... of a new series of brief, web-based audio interviews ... free to play or download at http://www.eheinc.com/ec_bits.htm ...
... /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, Inc. ("China ... CSKI ), a,leading fully integrated ... Republic of China ("PRC"), today announced that ... Pharmaceutical Company ("Jin,Chuang"), signed an exclusive distribution ...
... 24 Eiger BioPharmaceuticals, Inc.,a start-up biotechnology company ... million in a Series A financing co-led by ... instrumental in the formation,of the company and recruitment ... board of,directors by general partners Nina Kjellson and ...
Cached Biology Technology:Web-based Audio Interviews Keep Environment of Care Managers Up-to-Date on Key EC Compliance Issues 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 2China Sky One Medical, Inc. Signs Exclusive Distribution Agreement with Shaanxi Buchang Group for Naftopidil Dispersible Tablets 3Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round 2
(Date:5/16/2013)... the bone marrow in the liver, the spleen ... show that a specific type of immune cell facilitates ... hematopoiesis is essential for the function of the immune ... the liver and the spleen. Later the process is ... serves as the sole source of blood cells for ...
(Date:5/16/2013)... Ekwoge Enang Abwe, a conservationist working in Cameroon and ... program, has just been awarded the prestigious Whitley award. ... is often called "The Green Oscars" because it celebrates ... conservationists working in developing countries. Abwe was selected ... about and preserve Cameroon,s Ebo Forest and its wildlife ...
(Date:5/16/2013)... , May 16, 2013 ... Enhancement Award on Tuesday to Germany,s ... exceptional biometric border control system. DERMALOG has ... the Best Practices Award in the category Global Biometrics ... cutting edge Biometric   Border Control System . ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... within cells and increase a person,s susceptibility to bacterial ... new study published in Disease Models & Mechanisms ... bacteria Legionella , is facilitated by an increased ... mitochondrial disease. , Patients with mitochondrial disease exhibit a ...
... Brook, N.Y., July 27, 2009 - Temperature explains ... crustaceans, and lizards live longer at higher latitudes than ... in the Proceedings of the National Academy of ... Stephan Munch and Ph.D. candidate Santiago Salinas, both of ...
... Angeles, London, New Delhi, Singapore and Washington DC (July ... issue of Medical Decision Making , a large-scale, ... hospital resources even with an extremely effective public health ... attack and initiating a response to it. The ...
Cached Biology News:Stress signals link pre-existing sickness with susceptibility to bacterial infection 2Warmer environment means shorter lives for cold-blooded animals 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 2
... Simultaneously perform 96 assays on one plate. ... microarray plate with 96 (7mm x 7mm) ... gene expression, or screening analysis studies. Unlike ... fit gasket, eliminating the presence of contaminating ...
Bio-Plex Manager software, version 3.0, 5 license netshare, is a five-user software package that provides access to data from the Bio-Plex suspension array system from a server. This version does not...
... vapor-tight adhesive chambers for sealing hybridization reactions on ... a sample on a glass slide. Reaction solution ... the ports are then sealed with plastic sealing ... allow exchange of reaction fluid. These chambers enclose ...
... of integrins in vascular proliferation, adhesion, and ... family of cell adhesion receptors consists of ... an a and b subunit that associate ... functional diversity of the integrin family are ...
Biology Products: